IP Library Granted Patent US 9,364,413
Granted Patent B2
US 9,364,413 · App. 14/448,401 · Granted Jun 14, 2016

Method for anti-aging treatment by surfactin in cosmetics via enhancing sirtuin

Inventors: Jenn-Kan Lu (New Taipei, TW); Hsin-Mei Wang (Pingtung, TW); Xuan-Rui Xu (New Taipei, TW)
Assignees: UMO INTERNATIONAL CO., LTD.; Jenn-Kan Lu
A61K8/64A61K8/19A61K8/63A61K8/735A61Q19/08A61K2800/413A61K2800/651A61K2800/805
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,364,413
App. No.
14/448,401
Granted
Jun 14, 2016
Kind
B2
Abstract

Surfactin is a biosurfactant produced by Bacillus subtilis and is a natural cycloaliphatic peptide having a ring structure made of 7 amino acids. The surfactin has various functions including anti-aging, anti-wrinkle, increasing skin penetration of cosmetic products (skin penetration agent), foaming agent, and emulsifier.

Claims (29)

1. A method for an anti-aging treatment comprising:

administering a cosmetic composition to a subject in need thereof, wherein the cosmetic composition comprises surfactin in a concentration between 25-100 μm, and pharmaceutically acceptable vehicles, excipients, diluents or adjuvants,

wherein the cosmetic composition performs an antiaging effect via enhancement of sirtuin.

2. The method as recited in claim 1 , wherein the surfactin is a cycloaliphatic peptide comprising a hepapeptide (L)Glu-(L)Leu-(D)Leu-(L)Val-(L)Asp-(D)Leu-(L)Leu linked to a β-hydroxy fatty acid, and the distribution of the fatty acids at the fatty acid end of the surfactin are as follows:

(1) iso-C13>3%;

(2) C13>0.65%;

(3) iso-C14>17%;

(4) C14<41%; and

(5) iso-C15<11%.

3. The method as recited in claim 2 , wherein the distribution of the fatty acids at the fatty acid end of the surfactin are as follows:

(1) iso-C13>10%;

(2) C13>25%;

(3) iso-C14>35%;

(4) C14<25%; and

(5) iso-C15<3%.

4. The method as recited in claim 3 , wherein the distribution of the fatty acids at the fatty acid end of the surfactin are as follows: (1) iso-C13=11%; (2) C13=26%; (3) iso-C14=37%; (4) C14=24%; and (5) iso-C15=2%.

5. The method as recited in claim 1 , wherein the molecular weight of the surfactin is 1022 or 1036 Da.

6. The method as recited in claim 1 , wherein the surfactin comprises its isomers.

7. The method as recited in claim 1 , wherein the anti-aging cosmetic composition further comprises at least one of the following ingredients: alcohols, esters, complex polysaccharides, nut oils, and vitamins.

8. The method as recited in claim 7 , wherein the alcohol comprises at least one of the following: C16-18 alcohols, butanediol, pentanediol, octanediol, glycerin, hexadecanol, stearyl alcohol, 1-Docosanol and propylene glycol.

9. The method as recited in claim 7 , wherein the esters comprise at least one of the following: OLIVEM 1000, glycerol monostearate (GSM), isopropyl myristate (IPM), isopropyl palmitate (IPP) and triglycerides.

10. The method as recited in claim 7 , wherein the complex polysaccharides comprise at least one of the following: xanthan gum, Tremella fuciforinis polysaccharides, dextran polysaccharides, and Folium sennae seed polysaccharides.

11. The method as recited in claim 7 , wherein the nut oil comprises at least one of the following: Argan oil, Kukui nut oil, avocado oil, wheat germ oil, and olive oil.

12. The method as recited in claim 7 , wherein the vitamins comprise at least one of the following: vitamin A, vitamin B, vitamin C, vitamin E, vitamin F, and vitamin K.

13. The method as recited in claim 1 , wherein the anti-aging cosmetic composition is used to promote fibroblast proliferation, collagen production or sertuin 1 gene expression.

14. The method as recited in claim 1 , wherein the anti-aging cosmetic composition is used to prevent photoaging induced by UV light or anti-oxidation.

15. The method as recited in claim 1 , wherein the anti-aging cosmetic composition is used to inhibit matrix metallopeptidase.

16. The method as recited in claim 15 , wherein the matrix metallopeptidase is matrix metallopeptidase 9.

17. The method as recited in claim 1 , wherein the cosmetic composition comprises surfactin in a concentration between 50-75 μm, and pharmaceutically acceptable vehicles, excipients, diluents, or adjuvants.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2020
From: UMO INTERNATIONAL CO., LTD.; LU, JENN-KAN
To: UMO INTERNATIONAL CO., LTD.
Reel/Frame 052280/0678 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2014
From: LU, JENN-KAN; WANG, HSIN-MEI; XU, XUAN-RUI
To: UMO INTERNATIONAL CO., LTD.; LU, JENN-KAN
Reel/Frame 033454/0914 →
Continuity (1)
Related Publication 20160030322A1 · Feb 4, 2016